首页> 外文期刊>Crystal growth & design >Novel Synthons in Sulfamethizole Cocrystals: Structure-Property Relations and Solubility
【24h】

Novel Synthons in Sulfamethizole Cocrystals: Structure-Property Relations and Solubility

机译:磺胺甲二唑共晶体中的新型合成子:结构-性质关系和溶解度

获取原文
获取原文并翻译 | 示例
       

摘要

The sulfamethizole antibiotic drug has rich hydrogen bond functionalities (donors: amine NH2 and imine NH; acceptors: sulfonyl O, thiazolidine N and S, and imidine N), which makes it a functionally diverse molecule to form cocrystals. A cocrystal screen of sulfamethizole (SMT) with COOH, NH2, pyridine, and CONH2 functional group containing coformers, e.g., p-aminobenzoic acid (PABA), vanillic acid (VLA), p-aminobenzamide (ABA), 4,4-bipyridine (BIP), suberic acid (SBA), oxalic acid (OA), and adipic acid (ADP), resulted in six cocrystals and one salt, namely, SMT-ADP (1:0.5), SMT-PABA (1:1), SMT-VLA (1:1), SMT-ABA (1:1), SMT-BIP (1:1), SMT-SBA (1:0.5), and SMT-OA (1:1). The novel crystalline adducts were synthesized by liquid-assisted cogrinding and isothermal solvent crystallization. In addition to single-crystal X-ray diffraction, the phase composition of the powder samples was confirmed by powder X-ray diffraction (PXRD) and differential scanning calorimetry (DSC). Hydrogen bonding interactions between the coformers and SMT are analyzed as six different synthons. In addition to strong N-H center dot center dot center dot O and O-H center dot center dot center dot N hydrogen bonds, the cocrystal structures are sustained by weak C-H center dot center dot center dot O hydrogen bonds. The not so common chalcogen-chalcogen (S center dot center dot center dot O) type II intermolecular interaction in SMT-ADP cocrystal and chalcogen-nicogen (S center dot center dot center dot N) type II interaction in SMT-BIP cocrystal were observed. The products were characterized by vibrational spectroscopy to obtain information on the strengths of the intermolecular interactions. Solubility and dissolution experiments on SMT-ADP, SMT-SBA, and SMT-OA showed a lower intrinsic dissolution rate (IDR) and equilibrium solubility compared to SMT in 0.1 N HCl medium, which is ascribed to stronger N-H center dot center dot center dot O, N-H center dot center dot center dot N, and O-H center dot center dot center dot O hydrogen bonds and better crystal packing. The decreased IDR could be useful in controlled/extended release of SMT to improve therapeutic activity of the drug by minimizing its fast systemic elimination in vivo. Furthermore, we observed that SMT-OA salt is formed spontaneously when the components were mixed in acidic medium (0.1 N HCl), whereas in neutral medium (phosphate buffer) no SMT-OA salt formation was observed.
机译:磺胺甲二唑抗生素药物具有丰富的氢键官能团(供体:胺NH2和亚胺NH;受体:磺酰基O,噻唑烷N和S和亚胺N),使其成为功能多样的分子以形成共晶体。磺胺甲基咪唑(SMT)与含有COOH,NH2,吡啶和CONH2官能团的共形成物的共晶筛网,例如对氨基苯甲酸(PABA),香草酸(VLA),对氨基苯甲酰胺(ABA),4,4-联吡啶(BIP),辛二酸(SBA),草酸(OA)和己二酸(ADP)生成六种共晶体和一种盐,即SMT-ADP(1:0.5),SMT-PABA(1:1) ,SMT-VLA(1:1),SMT-ABA(1:1),SMT-BIP(1:1),SMT-SBA(1:0.5)和SMT-OA(1:1)。通过液相辅助共研磨和等温溶剂结晶合成了新型的结晶加合物。除了单晶X射线衍射外,还通过粉末X射线衍射(PXRD)和差示扫描量热法(DSC)确认粉末样品的相组成。共成型体和SMT之间的氢键相互作用被分析为六个不同的合成子。除了强的N-H中心点中心点中心点O和O-H中心点中心点中心点N氢键外,共晶体结构还由弱的C-H中心点中心点中心点O氢键维持。在SMT-ADP共晶体中观察到不太常见的硫族元素-硫属元素(S中心点中心点中心点O)II型分子间相互作用和在SMT-BIP共晶体中观察到硫属元素-硫属元素(S中心点中心点中心点N点)II型相互作用。通过振动光谱对产物进行表征,以获得有关分子间相互作用强度的信息。与SMT在0.1 N HCl介质中相比,在SMT-ADP,SMT-SBA和SMT-OA上进行的溶解度和溶出度实验显示出较低的固有溶出率(IDR)和平衡溶解度,这归因于较强的NH中心点中心点中心点O,NH中心点中心点中心点N和OH中心点中心点中心点O具有氢键和更好的晶体堆积。降低的IDR可用于SMT的控制/缓释,以通过最大程度地减少体内的快速全身消除作用来改善药物的治疗活性。此外,我们观察到在酸性介质(0.1 N HCl)中混合各组分时会自发形成SMT-OA盐,而在中性介质(磷酸盐缓冲液)中未观察到SMT-OA盐的形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号